↓ Skip to main content

Cochrane Database of Systematic Reviews

Botulinum toxin injections for low-back pain and sciatica

Overview of attention for article published in Cochrane database of systematic reviews, January 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

policy
1 policy source
twitter
2 tweeters
wikipedia
5 Wikipedia pages

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
201 Mendeley
Title
Botulinum toxin injections for low-back pain and sciatica
Published in
Cochrane database of systematic reviews, January 2011
DOI 10.1002/14651858.cd008257.pub2
Pubmed ID
Authors

Zeeshan Waseem, Chris Boulias, Allan Gordon, Farooq Ismail, Geoffrey Sheean, Andrea D Furlan

Abstract

Adequate relief from low-back pain (LBP) is not always possible. Emerging evidence suggests a role for botulinum neurotoxin (BoNT) injections in treating pain disorders. Proponents of BoNT suggest its properties can decrease muscle spasms, ischemia and inflammatory markers, thereby reducing pain.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 201 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Norway 1 <1%
Unknown 200 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 29 14%
Student > Bachelor 27 13%
Researcher 24 12%
Student > Postgraduate 20 10%
Student > Ph. D. Student 16 8%
Other 50 25%
Unknown 35 17%
Readers by discipline Count As %
Medicine and Dentistry 89 44%
Nursing and Health Professions 21 10%
Agricultural and Biological Sciences 13 6%
Psychology 6 3%
Pharmacology, Toxicology and Pharmaceutical Science 4 2%
Other 18 9%
Unknown 50 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 April 2021.
All research outputs
#3,764,353
of 20,968,855 outputs
Outputs from Cochrane database of systematic reviews
#6,313
of 12,061 outputs
Outputs of similar age
#31,478
of 173,947 outputs
Outputs of similar age from Cochrane database of systematic reviews
#50
of 125 outputs
Altmetric has tracked 20,968,855 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,061 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.5. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 173,947 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 125 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.